SuperGen (SUPG) Announces Departure of Chief Medical Officer
More News related to SUPG
- SuperGen Data Presentations at American Society of Hematology (ASH) Annual Meeting
- SuperGen to Present at Lazard Healthcare Conference on November 18, 2009
- SuperGen Presentations at AACR-NCI-EORTC
- Southwest IDEAS Conference Announces Presenting Company Lineup, Lunch Programs
- SuperGen to Present at Merriman Curhan Ford Investor Summit on November 10, 2009
More News related to Management Changes
- Metalline Mining (MMG) and Dome Ventures Agree to Merger Deal
- Pepsi (PEP) Company Completes Acquisition of Conway-Myrtle Beach Bottler
- Hershey (HSY), Nestle said to have been in contact about Cadbury (CBY)
- Kraft Singles Itself Out as Buyer for Cadbury
- Brookfield Positions To Bid for General Growth Properties (GGWPQ)
SuperGen, Inc. (NASDAQ: SUPG) announced that Gregory Berk, M.D., Chief Medical Officer, has left the Company.
Michael D. Young, M.D., Ph.D., a current member of the SuperGen board of directors and Chairman and Chief Scientific Officer of Strategic Healthcare Development, LLC, will serve as SuperGen's interim Chief Medical Advisor, consulting to James S. J. Manuso, Ph.D., President and Chief Executive Officer. Dr. Manuso will oversee both clinical and regulatory development until a replacement for Dr. Berk can be found. A global search for a new chief medical officer has been initiated.
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
Related Categories
Management ChangesStocks Mentioned
+0.21Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
